10 April 2006
Med Sci Monit 2006; 12(4): RA75-78 :: ID: 448936
Cellular therapy is the replacement of unhealthy or damaged cells or tissuesby new ones. Embryonic stem (ES) cells are undifferentiated cells that can generate all the cell typesof the body, and therefore hold the potential to cure a broad range of diseases and injuries, rangingfrom diabetis, liver and heart diseases, to neurological diseases, such as Alzheimer's and Parkinson'sdiseases. The derivation of human ES (hES) cells has been a major step toward bringing ES cell researchto therapy. However, there are several challenges to the advent of ES cell research to therapy. Amongthem, the derivation of hES cell lines devoid of animal contaminants, the maintenance of their normalkaryotypes, their potentials to form tumors upon grafting, and the derivation of isogenic hES cell lines.Stringent ethical and political guidelines are also limiting the use of human embryos for research, therebylimiting progress in ES cell research. Recently, several investigators have devised protocols to derivehES cells free of feeder layer and animal serum, reported that some established cell lines remain stableovertime, pre-differentiated ES cells in vitro to circumvent the risk of tumor formation, and derivedES cell lines without destroying embryos. In this manuscript, we will review and discuss these developmentsthat may unlock ES cell research and therapy.
Keywords: Cell Differentiation, Cell Culture Techniques, Cell Line, Cloning, Organism - ethics, Nuclear Transfer Techniques, Stem Cells - cytology
01 December 2022 : EditorialEditorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic
Med Sci Monit 2022; 28:e939088
29 November 2022 : Clinical ResearchRetrospective Study to Identify Risk Factors for Severe Disease and Mortality Using the Modified Early Warn...
Med Sci Monit In Press; DOI: 10.12659/MSM.938647
24 November 2022 : Clinical ResearchA Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vacc...
Med Sci Monit In Press; DOI: 10.12659/MSM.938665
01 December 2022 : EditorialEditorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Funga...
Med Sci Monit 2022; 28:e939088
05 Dec 2022 : Database AnalysisImpact of the De Ritis Ratio on the Prognosis of Patients with Stable Coronary Artery Disease Undergoing Pe...
Med Sci Monit In Press; DOI: 10.12659/MSM.937737
02 Dec 2022 : Clinical ResearchValue of Early Laparoscopic Exploration for Primary Infertile Patients with Patent Fallopian Tubes Complica...
Med Sci Monit In Press; DOI: 10.12659/MSM.938637
30 Nov 2022 : Clinical ResearchRetrospective Evaluation of Hematological and Clinical Factors Associated with 30-Day Mortality in 170 Pati...
Med Sci Monit In Press; DOI: 10.12659/MSM.938674
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996